ADHD: A scientific fact or a factual opinion? A critique of the veracity of attention deficit hyperactivity disorder

Emotional and Behavioural Difficulties

Volumn 14, Issue 2, 2009, Pages 127-140

  Visser, John ^a   Jehan, Zenib ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; Biomedical discourse; Truth

Indexed keywords

METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIOMEDICINE; BRAIN FUNCTION; CHILD HEALTH CARE; CLINICAL TRIAL; CULTURAL ANTHROPOLOGY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DISEASE MODEL; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; GENETIC SUSCEPTIBILITY; HEALTH CARE NEED; HUMAN; MEDICAL EDUCATION; MEDICAL PROFESSION; MEDICAL RESEARCH; MOLECULAR GENETICS; NEUROMODULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 68449100028     PISSN: 13632752     EISSN: 17412692     Source Type: Journal    
DOI: 10.1080/13632750902921930     Document Type: Article

References (89)

1. Baldwin, S. 2000a. Impact evaluation of a mass media public education campaign on clinical service provision for minors diagnosed with ADHD/ ADD: Audit survey of 100 index cases. International Journal of Risk and Safety in Medicine 13, no. 1: 203-445.
2. Baldwin, S. 2000b. Living in Britalin: Why are so many amphetamines prescribed to infants, children and teenagers in the UK? Critical Public Health 10, no. 4: 453-62.
3. Baldwin, S. and R. Anderson. 2000. The cult of methylphenidate: Clinical update. Critical Public Health 10, no. 1: 82.
4. Barkley, R.A. 1997a. Attention Deficit Hyperactivity Disorder and the nature of self control. London: Guilford Press.
5. Barkley, R.A. 1997b. Understanding Attention Deficit Hyperactivity Disorder and self-control: Social and clinical implications. In Attention Deficit Hyperactivity Disorder and the nature of self control ed. R.A. Barkley. London: Guilford Press.
6. Barkley, R.A. 1998. Attention-Deficit Hyperactivity Disorder. Scientific American 3, no. 3: 66.
7. Barkley, R.A. 2005. International consensus statement on ADHD. Clinical Child and Family Psychology Review 5, no. 2: 89-111.
8. Baughman, F.A. 1999. The totality of ADD/ADHD fraud. http://www.adhdfraud.com.
9. Baumeister, A.A, and M.F. Hawkins. 2001. Incoherence of neuroimaging studies of Attention Deficit Hyperactivity Disorder. Clinical Neoropharmacology 24, no. 6: 2-10.
10. Biederman, J., S.V. Faraone, M.C. Monuteux, and J.R. Grossbard. 2004. How informative are parentss' reports of Attention Deficit Hyperactivity Disorder symptoms for assessing outcome in clinical trials of long acting treatments? A pooled analysis of parents' and teachers' reports. Pediatrics 113, no. 6: 1667-71.
11. Breggin, P.R. 1999. Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action. International Journal of Risk and Safety in Medicine 12, no. 1: 3-35.
12. Breggin, P.R. 2000. A critical analysis of the NIMH multimodal treatment study for Attention Deficit Hyperactivity Disorder: The MTA study. International Journal of Risk and Safety in Medicine 13, no. 1: 15-22.
13. Breggin, P.R. 2002. The stimulant fact book. Cambridge: Perseus Books.
14. Bullmore, E. and P. Fletcher. 2003. The eye's mind: Brain mapping and psychiatry. British Journal of Psychiatry 182, no. 23: 381-4.
15. Busfield, J. 1986. Managing madness: Changing ideas and practice. London: Hutchinson.
16. Cantwell, D.P. 1999. Attention Deficit Disorder: A review of the past 10 years. Journal of American Child and Adolescent Psychiatry 35, no. 2: 978.
17. Carson, J. 2003. The culture of intelligence. In The Cambridge of science: The modern social sciences. Vol. 7. Cambridge: Cambridge University Press.
18. Cohen, D. 2004. Critiques of the 'ADHD' enterprise. In Critical new perspectives on ADHD, ed. G. Lloyd, J. Stead and D. Cohen. Oxford: Routledge.
19. Conrad, P. 2006. The shifting engines of medicalisation. Journal of Health and Social Behaviour 6, no. 3: 3-14.
20. Cooper, P. 1997. Biology, behaviour and education: AD/HD and the bio-psychosocial perspective. Educational and Child Psychology 14, no. 1: 31-42.
21. Cooper, P. 2001. Understanding AD/HD: A brief critical review of literature. Children and Society 15, no. 5: 387-95.
22. Cozza, S., G. Crawford and M. Dulcan. 2003. Treatment of children and adolescents. In American psychiatric publishing textbook of clinical psychiatry, Fourth Edition, ed. R. Hales and S. Yudofsky, 1399-454. Washington, DC: American Psychiatric Publishing.
23. Daley, D., E.J.S. Sonuga-Burke, T. Thompson and W. Chen. 2008. Gene social environment interplay in relation to Attention Deficit Hyperactivity Disorder. Psychiatry 7: 520-4.
24. Daly, G., Z. Hawi, M. Fitzgerald, and M. Gill. 1999. Mapping susceptibility loci in Attention Deficit Hyperactivity Disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Molecular Psychiatry 56, no. 1: 192-6.
25. Data Trends. 2002. Summaries of research on mental health services for children and adolescents and their families.: Research and training centre for children's mental health. http://www.datatrends.fmhi.usf.edu
26. Diller, L.H. 2006. The last normal child: Essays on the intersection of kids, culture and psychiatric drugs. New York: Praeger.
27. Fairclough, N. 1992. Critical language awareness. London: Longman.
28. Farah, M. 2002. Emerging ethical issues in neuroscience. Nature and Neuroscience 5, no. 11: 835-40.
29. Faraone, S.V. 2005. The scientific foundation for understanding Attention-Deficit/Hyperactivity Disorder as a valid psychiatric disorder. European Child and Adolescent Psychiatry 14, no. 1: 1-10.
30. Faraone S.V., and A.E. Doyle. 2001. The nature and heritability of Attention-Deficit/Hyperactivity Disorder. Child Adolescent Psychiatry Clinical North America 2, no. 2: 299-316.
31. Faraone, S.V, R.H. Perlis, A.E. Doyle, J.W. Smoller, J. Goralnick, and M.A. Holmgren. 2005. Molecular genetics of Attention Deficit Hyperactivity Disorder. Biological Psychiatry 57, no. 11: 1313-23.
32. Fineman, M. 2001. Why is someone Attention Deficit Hyperactivity Disorder? The New England Sceptical Society 4, no. 2: 45-51.
33. Fone, K. and D. Nutt. 2005. Stimulants: Use and abuse in the treatment of ADHD. Current Opinion in Pharmacology 5, no. 4: 87-95.
34. Foucault, M. 1972. The archaeology of knowledge. New York: Pantheon Books.
35. Foucault, M. 1977. Discipline & punish: The birth of the prison. London: Penguin Books.
36. Foucault, M. 1980. Power/knowledge: Selected interviews & other writings - 1972-1977. New York: Pantheon Books.
37. Fuster, J.M. 1997. The prefrontal cortex: Anatomy physiology and neuropsychology of the frontal lobe. New York: Raven.
38. Ghodse, A.H. 2007. 'Uppers' keep going up. British Journal of Psychiatry 191, no. 87: 279-81.
39. Graham, L. 2005. Discourse analysis & the critical use of Foucault. Australian Association for Research in Education 34, no. 12: 1-14.
40. Graham, L. 2006. Done by discourse ⋯ or the problem/s with labeling. In Schools & Diversity, eds. M. Keeffe and S. Carrington. Sydney: Pearson Education.
41. Graham, L. 2008. From ABCs to ADHD: The role of schooling in the construction of behaviour disorder and production of disorderly objects. International Journal of Inclusive Education 12, no. 1: 2-7.
42. Hay, D.A., K.S. Bennett, F. Levy, J. Sergeant, and J. Swanson. 2007. A twin study of Attention Deficit Hyperactivity Disorder: Dimensions rated by the strengths and weaknesses of Attention Deficit Hyperactivity Disorder Symptoms and Normal Behaviour (SWAN) Scale. Biological Psychiatry 61, no. 2: 700-15.
43. Holowenko, H. 1999. ADHD a multi disciplinary approach. London: Jessica Kingsley.
44. Jacobson, K. 2006. ADHD from a cross cultural perspective: Insight into adult-child power relationship. In Critical New Perspectives on ADHD eds. G. Lloyd, J. Stead, and D. Cohen. Oxford: Routledge.
45. Li, D., P.C. Sham, M.J. Owen, and L. He. 2006. Meta analysis shows significant association between dopamine system genes and Attention Deficit Hyperactivity Disorder. Human Molecular Genetics 15, no. 4: 2276-84.
46. Lloyd, G., and C. Norris. 1999. Including ADHD. Disability and Society 14, no. 4: 505.
47. Lloyd, G., J. Stead, and D. Cohen. 2006. Critical new perspectives on ADHD. Oxford: Routledge.
48. MacCoun, R.J. 1998. Biases in the interpretation and use of research results. Annual Review of Psychology 49, no. 2: 259-87.
49. Manor, I., J. Eisenberg, S. Tyano, Y. Sever, H. Cohen, R.P. Ebstein, and M. Kotler. 2001. Family based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in Attention Deficit Hyperactivity Disorder. American Journal of Medical Genetics 105, no. 1: 91-5.
50. McCracken, J.T. 1998. Attention-Deficit Disorder II: Neuropsychiatric aspects. In Textbook of pediatric neuropsychiatry, eds. R. Brumbach, and E. Coffey. New York: American Association Press.
51. McCracken, J.T., S.L. Smalley, J.J. McGough, L. Crawford, M. Del'Homme, R.M. Cantor, A. Liu, and S.F. Nelson. 2000. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with Attention Deficit Hyperactivity Disorder (ADHD). Molecular Psychiatry 5, no. 5: 531-6.
52. Miller, T., and M.C. Leger. 2003. A very childish moral panic: Ritalin. Journal of Medical Humanities 24, no. 1: 9-33.
53. MTA Cooperative Group. 1999a. 14 months randomised clinical trial of treatment strategies for Attention Deficit Hyperactivity Disorder. Archive of General Psychiatry 56, no. 12: 1073-86.
54. MTA Cooperative Group. 1999b. Moderators and mediators of treatment response for children with Attention Deficit Hyperactivity Disorder. Archive of General Psychiatry 56, no. 12: 1088-96.
55. MTA Cooperative Group. 2004. NIMH follow up: 24 month outcomes of treatment strategies for Attention Deficit Hyperactivity Disorder. Pediatrics 114, no. 2: 514-24.
56. National Institute of Health and Clinical Excellence. (NICE). 2008. NICE counsels caution on drug use in ADHD. Chemist and Druggist 269, no. 63: 5-9.
57. Neitzsche, F. 1967. The will to power. New York: Random House.
58. Norris, C., and G. Lloyd. 2000. Parents, professionals and ADHD: What the papers say. European Journal of Special Needs Education 15, no. 22: 123-37.
59. Oak, E. 2004. What's in a name? ADHD and social role valorization theory; its relevance for development. International Journal of Disability, Community and Rehabilitation 3, no. 1: 1-11.
60. Orden, G.C.V., and K.R. Paap. 1997. Functional neuroimages fail to discover pieces of mind in the parts of the brain. Philosophy of Science 64, no. 4: 885-94.
61. Papineau, D. 1994. Mental disorders, illnesss & biological dysfunction. In Philosophy, psychology & psychiatry, eds. P.A. Griffiths. 1994. Cambridge: Cambridge University Press.
62. Pellegrini, A.D., and M. Horvat. 1995. A developmental contexualist critique of Attention Deficit Hyperactivity Disorder. Educational Researcher 24, no. 1: 13.
63. Rafalovich, A. 2001. Psychodynamic and neurological perspectives on ADHD: Exploring strategies for defining a phenomenon. Journal for the Theory of Social Behaviour 31, no. 44: 397-418.
64. Rafalovich, A. 2005. Exploring clinician uncertainty in the diagnosis and treatment of ADHD. Sociology of Health and Illness 27, no. 3: 305-23.
65. Rafalovich, A. 2007. Suffer the restless children: The evolution of ADHD and paediatric stimulant use - 1900-1980. History of Psychiatry 18, no. 4: 435-57.
66. Rappley, M.D. 2005. Attention deficit hyperactivity disorder. The New England Journal of Medicine 352, no. 2: 165-73.
67. Rose, H., and S.P.R. Rose. 2000. Alas, poor Darwin. London: Jonathan Cape.
68. Schachar, J.R., and R. Tannock. 1997. Behavioural, situational, and temporal effects of treatment of ADHD with methylphenidate. Journal of American Academy of Child and Adolescent Psychiatry 36, no. 6: 754-63.
69. Shah, S. 2008. Unraveling the mystery of ADHD. The Pharmaceutical Journal 280, no. 7489: 191-4.
70. Slee, R 1996. Inclusive education in Australia. Cambridge Journal of Education 26, no. 1: 19-32.
71. Stevenson, J., P. Asherson, D. Hay, F. Levy, J. Swanson, A. Thapar, and E. Willcutt. 2005. Characterising the Attention Deficit Hyperactivity Disorder: Phenotype for genetic studies. Developmental Science 8, no. 2: 115-21.
72. Swanson, J. 1993. Effect of stimulant medication on hyperactive children: A review of reviews. Exceptional Child 60, no. 6: 154-61.
73. Swanson, J.M. 2001. Clinical relevance to the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of the treatment. Journal of American Academy of Child and Adolescence Psychiatry 40, no. 3: 168-79.
74. Swanson, J., P. Flodman, J. Kennedy, M.A. Spence, R. Moyzis, S. Shuck, M. Murais, C. Moriarity-Barr, M. Smith and M. Posner. 2000. Dopamine, genes and Attention Deficit Hyperactivity Disorder. Neuroscience and Biobehavioural Review 31, no. 3: 21-32.
75. Szasz, T.S. 2001. Pharamacracy: Medicine and politics in America. New York: Praeger.
76. Szasz, T. 2000. Chemical straitjackets for children. Ideas on Liberty 50, no. 4: 38-48.
77. Tait, G. 2001. Pathologising difference, governing personality. Asia Pacific Journal of Teachers Education 29, no. 3: 93-108.
78. Tait, G. 2005. The ADHD debate and the philosophy of truth. International Journal of Inclusive Education 9, no. 1: 17-38.
79. Tait, G. 2006. A brief philosophical examination of ADHD. In Critical new perspectives on ADHD, eds. G. Lloyd, J. Stead, and D. Cohen. 2006. Oxford: Routledge.
80. Tannock, R. 1998. ADHD: Advances in cognitive, neurobiological, and genetic research. Journal of Child Psychology and Psychiatry 39, no. 1: 65-99.
81. Timimi, S. 2004. A critique of the international consensus statement on ADHD. Clinical Child and Family Psychology 7, no. 1: 59-63.
82. Timimi, S. 2008. Child psychiatry and its relationship with the pharmaceutical industry: Theoretical and practical issues. Advances in Psychiatric Treatment 14, no. 1: 3-9.
83. Timimi, S., and E. Taylor. 2004. ADHD is best understood as a cultural construct. British Journal of Psychiatry 184, no. 65: 8-9.
84. Todd, R.D. 2000. Genetics of Attention Deficit Hyperactivity Disorder: Are we ready for molecular studies? American Journal of Medical Genetics 96, no. 3: 241-3.
85. Todd, R.D., and K. O'Malley. 2001. The dopamine receptor DRD4 gene: Are duplication distracting? Clinical update: Trends in pharmacological sciences 22, no. 2: 612-6.
86. Travell, C., and J. Visser. 2006. ADHD does bad stuff to you: Young people's and parents' experiences and perceptions of Attention Deficit Hyperactivity Disorder (ADHD). Emotional and Behavioural Difficulties 11, no. 3: 205-16.
87. Volkow, N., and J. Swanson. 2003.Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. American Journal of Psychiatry 160, no. 23: 1909-18.
88. Waldman, I.D., D.C. Rowe, A. Abramowitz, S.T. Kozel, J.H. Mohr, and S.L. Sherman 1998. Association and linkage of the dopamine receptor gene and Attention Deficit Hyperactivity Disorder in children: Heterogeneity owing to diagnostic subtypes and severity'. American Journal of Human Genetics 63, no. 6: 1767-76.
89. Williams, J., and E. Taylor. 2006. The evolution of hyperactivity, impulsivity and cognitive diversity. Journal of the Royal Society 3, no. 1: 399-405.